|

SIM0505 for injection Clinical Trials

1 actively recruiting trial across 1 location

No change since July 2026

Pipeline

Phase 1: 1

Top Sponsors

  • NextCure, Inc.1

Indications

  • Uterine Serous Carcinoma (USC)1
  • Papillary Renal Cell Carcinoma (Prcc)1
  • Platinum-resistant Ovarian Cancer1
  • Renal Cell Carcinoma (RCC)1
  • NSCLC (Non-small Cell Lung Cancer)1

Orlando, Florida1 trial

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Sarah Cannon Research Institute (SCRI) - Lake Nona

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.